Plasma exchange versus intravenous immunoglobulin treatment in myasthenic crisis
Authors:
- 1 February 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 52 (3) , 629
Abstract
Article abstract We performed a retrospective multicenter chart review to compare the efficacy and tolerance of plasma exchange (PE) and intravenous immunoglobulin (IVIg) in treatment of 54 episodes of myasthenic crisis. After adjustment for other variables, PE (compared with IVIg) was associated with a superior ventilatory status at 2 weeks (partial F = 6.2, p = 0.02) and 1 month functional outcome (partial F = 4.5, p = 0.04). However, the complication rate was higher with PE compared with IVIg (13 versus 5 episodes, p = 0.07).Keywords
This publication has 7 references indexed in Scilit:
- Therapy of myasthenic crisisCritical Care Medicine, 1997
- Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravisAnnals of Neurology, 1997
- Myasthenic crisisNeurology, 1997
- Myasthenic CrisisArchives of Neurology, 1993
- Acute Renal Failure Resulting From Intravenous Immunoglobulin TherapyArchives of Neurology, 1993
- Experience with intravenous immunoglobulin in myasthenia gravisClinical Immunology and Immunopathology, 1989
- Letters to the editorMuscle & Nerve, 1983